Literature DB >> 17387196

Active pulmonary tuberculosis: experience with resection in 106 cases.

Rishendran Naidoo1.   

Abstract

The surgical management of pulmonary tuberculosis has evolved since collapse therapy was the mainstay of treatment. Despite this, resection for active tuberculosis is viewed with circumspection. Details of 106 patients with pathologically proven active pulmonary tuberculosis, who were operated on from January 1997 to January 2005, were reviewed retrospectively. Demographic data, radiographic profiles, indications for surgery, sputum status, and preoperative drug therapy were analyzed in relation to outcomes. The indications for surgery included multidrug-resistant tuberculosis in 27 patients, hemoptysis in 44, bronchiectasis in 27, and diagnostic dilemmas where a tumor could not be excluded in 8. All patients were operated on while receiving antituberculous therapy, and 17 were sputum positive at the time of surgery. Two (1.9%) patients died postoperatively. Morbidity was 16.9%, including 6 cases of postpneumonectomy empyema and one of bronchopleural fistula. Surgery for active tuberculosis may be undertaken with acceptable morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17387196     DOI: 10.1177/021849230701500211

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  10 in total

Review 1.  Surgical treatment of drug-resistant tuberculosis.

Authors:  Russell R Kempker; Sergo Vashakidze; Nelly Solomonia; Nino Dzidzikashvili; Henry M Blumberg
Journal:  Lancet Infect Dis       Date:  2012-02       Impact factor: 25.071

Review 2.  Post-resection complications: abscesses, empyemas, bronchopleural fistulas.

Authors:  Matthew Egyud; Kei Suzuki
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 3.  Surgery and pleuro-pulmonary tuberculosis: a scientific literature review.

Authors:  Dragan Subotic; Piotr Yablonskiy; Giorgia Sulis; Ioan Cordos; Danail Petrov; Rosella Centis; Lia D'Ambrosio; Giovanni Sotgiu; Giovanni Battista Migliori
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

Review 4.  Resurgence of therapeutically destitute tuberculosis: amalgamation of old and newer techniques.

Authors:  Ravindra Kumar Dewan; Loven Moodley
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

Review 5.  The medical and surgical treatment of drug-resistant tuberculosis.

Authors:  Gregory L Calligaro; Loven Moodley; Greg Symons; Keertan Dheda
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

6.  Pulmonary resection in the treatment of 43 patients with well-localized, cavitary pulmonary multidrug-resistant tuberculosis in Shanghai.

Authors:  Boxiong Xie; Yang Yang; Wenxin He; Dong Xie; Gening Jiang
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-06-07

7.  Pulmonary resection for extensively drug resistant tuberculosis in Kwazulu-Natal, South Africa.

Authors:  Adam Iddriss; Nesri Padayatchi; Darshan Reddy; Anu Reddi
Journal:  Ann Thorac Surg       Date:  2012-05-24       Impact factor: 4.330

Review 8.  Retrospective study of clinical and lesion characteristics of patients undergoing surgical treatment for Pulmonary Tuberculosis in Georgia.

Authors:  Sergo Vashakidze; Albert Despuig; Shota Gogishvili; Keti Nikolaishvili; Natalia Shubladze; Zaza Avaliani; Nestan Tukvadze; Martí Casals; Joan A Caylà; Pere-Joan Cardona; Cristina Vilaplana
Journal:  Int J Infect Dis       Date:  2016-12-19       Impact factor: 3.623

9.  Comparison of outcome of surgery for tubercular and nontubercular empyema: An analysis of 285 consecutive cases.

Authors:  Arvind Kumar; C Vijay Lingaraju; Mohan Venkatesh Pulle; Belal Bin Asaf; Harsh Vardhan Puri; Sukhram Bishnoi
Journal:  Lung India       Date:  2021 Nov-Dec

10.  Pulmonary resection in the treatment of multidrug-resistant tuberculosis: A case series.

Authors:  Lin Wang; Fan Xia; Feng Li; Xueqin Qian; Yijun Zhu; Hui Chen; Aoao Bian; Jun Wang; Min Zhang; Hongwei Li; Jiafu Han; Nan Jiang; Ning Xu; Yanzheng Song
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.